ACCREDITATION STATEMENTS

• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Diabetes + Wellness Summit. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity. 
• DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 3.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• DPM: Des Moines University (DMU) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. DMU has approved this activity for a maximum of 3.5 continuing education contact hours.
• Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 3.5 continuing education contact hour(s). Nurses must attend the entire session within each day to receive credit. Partial session credit is prohibited and will be forfeited.
• Other Health Professionals: This live activity is designated for a maximum of 3.5 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No commercial interest company provided financial support for this continuing education activity.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. 

Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.

• Denise Attard Sacco, MPH, CHES, Speaker
• Michael Boyson, MHA, Planning Committee Member
• Rachel Finkelstein, PharmD, BCACP, Planning Committee Member
• Wesley Franklin, Planning Committee Member
• Ali Grossman, MA, RDN, LD, Speaker
• Laurene Hendricks, Planning Committee Member
• Carol Hibbs, Planning Committee Member
• Mary Kaufmann, MS, RDN, LD, CDE, MA, BCC, Planning Committee Member
• Allen Kempf, DPM, MS, Speaker
• Tracy Keninger, Planning Committee Member
• Meredith Koob, Planning Committee Member
• Kathleen Kunath, RN, Planning Committee Member
• Nicholas Lamoureux, MS, PhD(C), Speaker
• Andrew Minear, MPH, Planning Committee Member
• Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, FAPhA, Activity Director and Speaker
• Tracy Porter, PT, DPT, EdD, Speaker
• Trina Radske-Suchan, PT, CSCS, Planning Committee Member
• Josie Redman, MHA, Speaker
• Kady Reese, MPH, CPHQ, Planning Committee Member
• Cari Seddon, MA, RDN, LD, CDCES, Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

• Lawrence (Larry) Fischer, PhD, ABPP, Speaker, is a consultant for Ascensia Diabetes Care and has received grant or research support from Eli Lilly.
• Amanda Gymer, Speaker, is an employee of Diabetic Equipment and Supplies.
• Eric Martin, MD, FACC, FASE, FASNC, FSCCT, FSCMR, Speaker, is a member of the speaker bureau for Boehringer-Ingelheim and Astra Zeneca.

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.